BOUDNÝ, Miroslav, Jana ZEMANOVÁ, Marek BORSKÝ, Michaela HLOŽKOVÁ, Jitka MALČÍKOVÁ, Eva DIVÍŠKOVÁ, Yvona BRYCHTOVÁ, Kamil PARUCH and Martin TRBUŠEK. Potenciál inhibice proteinu Chk1 u chronické lymfocytární leukémie s mutacemi v genu TP53. (90/5000 Potential for the inhibition of Chk1 protein in chronic lymphocytic leukemia with mutations in the TP53 gene). In XXXI. Olomoucké hematologické dny. 2017.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Potenciál inhibice proteinu Chk1 u chronické lymfocytární leukémie s mutacemi v genu TP53.
Name (in English) 90/5000 Potential for the inhibition of Chk1 protein in chronic lymphocytic leukemia with mutations in the TP53 gene
Authors BOUDNÝ, Miroslav (203 Czech Republic, belonging to the institution), Jana ZEMANOVÁ (203 Czech Republic, belonging to the institution), Marek BORSKÝ (203 Czech Republic, belonging to the institution), Michaela HLOŽKOVÁ (203 Czech Republic, belonging to the institution), Jitka MALČÍKOVÁ (203 Czech Republic, belonging to the institution), Eva DIVÍŠKOVÁ (203 Czech Republic, belonging to the institution), Yvona BRYCHTOVÁ (203 Czech Republic, belonging to the institution), Kamil PARUCH (203 Czech Republic, belonging to the institution) and Martin TRBUŠEK (203 Czech Republic, belonging to the institution).
Edition XXXI. Olomoucké hematologické dny, 2017.
Other information
Original language Czech
Type of outcome Conference abstract
Field of Study 10606 Microbiology
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/17:00096948
Organization unit Faculty of Medicine
Keywords in English TP53; CLL; Chk1
Changed by Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 14/2/2018 13:42.
Abstract
Potenciál inhibice proteinu Chk1 u chronické lymfocytární leukémie s mutacemi v genu TP53, Potenciál inhibice proteinu Chk1 u chronické lymfocytární leukémie s mutacemi v genu TP53
Abstract (in English)
Potenciál inhibice proteinu Chk1 u chronické lymfocytární leukémie s mutacemi v genu TP53, Potenciál inhibice proteinu Chk1 u chronické lymfocytární leukémie s mutacemi v genu TP53
Links
MUNI/A/1106/2016, interní kód MUName: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit IV (Acronym: VýDiTeHeMA IV)
Investor: Masaryk University, Category A
16-32743A, interní kód MU
(CEP code: NV16-32743A)		Name: Predictive stratification of CLL patients for therapy involving monoclonal antibodies targeting CD20 (Acronym: CLLAB20)
Investor: Ministry of Health of the CR
PrintDisplayed: 15/7/2024 21:55